NEW YORK (GenomeWeb News) – Luminex today announced that its public offering of 3.5 million shares of common stock, which is expected to close on June 30, will price at $19.91 per share.
 
The Austin, Texas-based firm expects to realize net proceeds of $64.5 million from the offering. It also has granted underwriters a 30-day option to acquire an additional 525,000 shares of common stock to cover any over-allotments.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.